Dr. Anjana Pillai explains, in an interview with CURE, that treatment for liver cancer depends heavily on stage, liver function and a person’s overall health. For those diagnosed at very early or ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high ...
Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...
Polyembo, a privately held medical device company founded to develop the Scrunchy, Sphere, PuffyCoil, and other vascular ...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from ...
A research team from Shanghai Jiao Tong University School of Medicine has developed an innovative surgical technique — known as FENCY ligation — combined with preoperative embolization to improve the ...
Hypervascular tumors of the brain and spinal cord pose serious challenges for neurosurgeons due to their dense blood vessel networks, which can lead to heavy bleeding and increased surgical risk. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback